Clinical Trial

Solv Multi-Pass Hemodialysis System In-Center Clinical Study

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 1, 2026 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
Solv In-Center clinical study is a pre-market, prospective, multicenter, single arm, open-label clinical study. The patient population will include patients with kidney failure or insufficiency requiring hemodialysis and/or ultrafiltration. Eligibility will be open to incident dialysis patients and patients currently receiving HD in an in-center environment. All vascular access types including AV-fistula, AV-graft, and tunneled hemodialysis catheters.
Protocol Amendment History 1 change
notable Sponsor changed: Medtronic - MITG -> Mozarc Medical US LLC 2026-04-02
Trial Details
NCT Number NCT07216885
Lead Sponsor Mozarc Medical US LLC
Conditions End Stage Renal Disease
Enrollment 46 participants
Start Date 2026-01-13
Primary Completion 2026-07 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2026-04-01